The Importance of Customer Service in Pharmaceutical Contract Manufacturing

Publisher: Aphena Pharma Solutions

Access this content

Your content has been opened.

Please verify you are a human before downloading this content.

The Importance of Customer Service in Pharmaceutical Contract Manufacturing has been emailed to . Entered the wrong email?

Don't see the content in your inbox?
Make sure to check your spam and other messages folders.

Can't get to your email right now?

To complete your registration and access this content, enter the sign-in code sent to your email.

Please enter a valid verification code.

Code sent to:

Also, remember to check in your spam, promotions, and other folders.

Register to access this content

By accessing content on the Pharmaceutical Manufacturing Resource Directory you agree to our Terms of Service and Privacy Policy; and, you acknowledge that your information may be shared with the content publisher.

The Importance of Customer Service in Pharmaceutical Contract Manufacturing

With tightening regulations and rising costs, the pharmaceutical industry is being presented with a consistent challenge in the marketplace: Do more with less. As a result, pharma companies are reducing their internal capacities in manufacturing and R&D and are, instead, increasing their outsourcing.

Similar content you might be interested in

Wash Station/Cleaning Systems for Process Equipment

Publisher: Custom Powder Systems, the Containment Company

Wash Station/Cleaning Systems for Process Equipment

Sanitize and dry containers or other process equipment including bins, drums, fluid bed bowls, downspouts, pallets and other parts with repeatable and validatable cleaning systems, designed to meet your specific cleaning requirements.

Download Content »

Leverage on Serialization Investments with Aggregation

Publisher: Dec Group

Leverage on Serialization Investments with Aggregation

As pharmaceutical suppliers around the globe are preparing to meet the deadline for serialization compliance, the question naturally arises what the next step should be. The answer? Aggregation: linking individual products to their secondary and even tertiary packaging. This whitepaper will take you through the ‘what, why, where, who, when & how’ of the concept and execution of aggregation.

Download Content »

Uploaded From lab-bench to large-scale production

Publisher: Frewitt

Uploaded From lab-bench to large-scale production

In formulation development, the scale-up from a lab-bench production of small batches to a large-scale production due to a demand for bigger batches, e.g. for clinical trials or economic reasons, can often be challenging. Thus, the possibility to scale-up the manufacturing process is imperative for the success of a new formulation and should be evaluated during early stages of development. This applies to the production of nanocrystals (NC), which can be used to enhance the skin penetration properties of promising actives in the field of skin therapy, such as the flavonoid curcumin [1-3]. Curcumin is isolated from the rhizome of turmeric and acts as a selective inhibitor of the enzyme phosphorylase kinase. This leads to a positive effect on dermal wound healing after topic application with less inflammation and reduced scarring [2]. However, it shows an insufficient skin penetration, due to its poor aqueous solubility and low bioavailability [1]. Thus, the development of a suitable formulation for curcumin is crucial for its later use in therapy. After formulation development, low energy nanomilling with the NanoWitt-LAB 100 milling equipment enables an easy scale-up of the NC production in continuous operation. Therefore, it can be used as a suitable manufacturing process to determine the feasibility of a largescale production.

Download Content »